PARP4 Polyclonal Antibody, AbBy Fluor™ 647 Conjugated
Product Specifications
Background
Component of the vault ribonucleoprotein particle which is at least composed of MVP, PARP4 and one or more vault RNAs (vRNAs) . Binds to MVP. Associates with TEP1. Widely expressed; the highest levels are in the kidney; also detected in heart, placenta, lung, liver, skeletal muscle, spleen, leukocytes and pancreas.
Synonyms
PARP related / IalphaI related H5 / proline rich; Vault poly ADP ribose polymerase; VPARP; 193kDa vault protein; ADP ribosyltransferase NAD+ poly ADP ribose polymerase like 1; ADP ribosyltransferase like 1; ADPRT L1; ADPRTL 1; ADPRTL1; H5 proline rich; I alpha I related; KIAA0177; Minor vault p193 protein; p193 antibody PARP 4; PARP related; PARPL; PH 5P; PH5P; Poly ADP ribose polymerase 4; Poly ADP ribose polymerase family member 4; Poly ADP ribose synthetase; Poly ADP ribosyl transferase like 1; Poly ADP ribose polymerase 4; Poly ADP ribose polymerase family member 4; Vault 3; Vault; Vault poly ADP ribose polymerase; Vault protein 193 kDa; Vault3; PARP4_HUMAN.
Gene ID
143
Cellular Locus
Cytoplasm, Nucleus
Host
Rabbit
Cross Reactivity
Rat
Immunogen
851-950/1724
Target
PARP4
Clonality
Polyclonal
Isotype
IgG
Conjugation
AbBy Fluor™ 647
Source
KLH conjugated synthetic peptide derived from human PARP4
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
650nm/665nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
143
Predicted Cross Reactivity
Human, Mouse, Sheep, Pig, Rabbit
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL711254V 500 µL Each
Tgfb2 Rat shRNA Lentiviral Particle (Locus ID 81809)
Sign In for Pricing
View Details 
